4th Quarter - Report
MCDERMOTT+ LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING
Firm
Income
$30,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 2543 - Prescription Drug Pricing Reduction Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 133 - Consolidated Appropriations Act, 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Medicare/Medicaid MMM
H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act of 2019 Rebate Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Pharmacy PHA
S. 1895 - Lower Health Care Costs Act S. 2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.